Mads Krogsgaard Thomsen
CEO · Novo Nordisk Fonden
CEO at Novo Nordisk Fonden. Listed as an officer, director, or key employee across 1 organization on the Form 990 record.
This is meWho this is
Profile
Everything on the left is verified from the IRS filings. The biography on the right is compiled from public web sources and grounded to that filed record.
Mads Krogsgaard Thomsen is a Danish pharmaceutical executive who has been CEO of the Novo Nordisk Foundation since March 2021, leading one of the world's largest endowments with a net worth of nearly $100 billion USD. He previously served as Executive Vice President of R&D and Chief Science Officer at Novo Nordisk, where he led the development of GLP-1 therapies for type 2 diabetes and obesity treatments.
Track record
Career & tenure
Real tenure, career, and education — from public web sources, what you need to vet a founder or leader beyond the filing window.
Verify independently
Find them online
Primary links to check this person directly — their own pages, not an aggregator.
Affiliations
Organizations
Network
Serves alongside
Other officers, directors & key employees at this person's organizations, by latest reported compensation.
Network
Recommendations
Written by other verified members of the network — visible once you're a verified person yourself.
Loading…
Explore
Similar organizations
Nonprofits working in the same field — explore who else operates in this space.
People like this
Similar leaders
Leaders at organizations in the same field, by reported compensation.